\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ verrucous\\,\\ hyperkeratotic\\,\\ well\\ circumscribed\\ plaque\\ on\\ bilateral\\ labia\\ minora\\.\ \(0\)\
\-\ treatment\\/course\\:\\ reassurance\\.\\ excision\\ was\\ offered\\,\\ but\\ deferred\\.\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ neutrophils\\ within\\ the\\ stratum\\ corneum\\,\\ parakeratosis\\,\\ and\\ marked\\ epidermal\\ hyperplasia\\ without\\ significant\\ atypia\\.\\ the\\ papillary\\ dermis\\ contains\\ foamy\\ cells\\ with\\ acute\\ and\\ chronic\\ inflammation\\.\\ pas\\ stains\\ were\\ negative\\ for\\ fungi\\.\ \(0\)\
\-\ case\\ 16\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ verruciform\\ xanthoma\ \(0\)\
\-\ history\\:\\ 33\\-year\\-old\\ female\\ with\\ turner\\'s\\ syndrome\\,\\ htn\\,\\ hypothyroidism\\ and\\ hypercholesterolemia\\ presents\\ with\\ a\\ one\\ year\\ history\\ of\\ asymptomatic\\ lesion\\ of\\ the\\ vulva\\.\\ the\\ lesion\\ had\\ an\\ insidious\\ onset\\ and\\ was\\ not\\ associated\\ with\\ bleeding\\,\\ ulceration\\,\\ or\\ crusting\\.\\ there\\ was\\ no\\ history\\ of\\ local\\ trauma\\ or\\ venereal\\ disease\\.\\ the\\ lesion\\ did\\ not\\ respond\\ to\\ three\\ months\\ of\\ twice\\ daily\\ application\\ of\\ a\\ high\\ potency\\ steroid\\.\\ she\\ had\\ a\\ history\\ of\\ hpv\\ and\\ abnormal\\ pap\\ smears\\.\\ treatment\\ with\\ aldara\\ did\\ not\\ alter\\ the\\ lesion\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hyperkeratotic\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ treatment\\/course\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ stratum\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ corneum\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ verruciform\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ vulva\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ aldara\\:\\ 0\\.050956753895760105\ \(0\)\
\-\ verrucous\\:\\ 0\\.04695012279425753\ \(0\)\
\-\ minora\\:\\ 0\\.04695012279425753\ \(0\)\
\-\ parakeratosis\\:\\ 0\\.04695012279425753\ \(0\)\
\-\ venereal\\:\\ 0\\.04695012279425753\ \(0\)\
\-\ potency\\:\\ 0\\.04460639384565542\ \(0\)\
\-\ labia\\:\\ 0\\.04294349169275496\ \(0\)\
\-\ foamy\\:\\ 0\\.04294349169275496\ \(0\)\
\-\ crusting\\:\\ 0\\.04294349169275496\ \(0\)\
\-\ hpv\\:\\ 0\\.04294349169275496\ \(0\)\
\-\ 33\\-year\\-old\\:\\ 0\\.04165364457533178\ \(0\)\
\-\ reassurance\\:\\ 0\\.04059976274415285\ \(0\)\
\-\ xanthoma\\:\\ 0\\.04059976274415285\ \(0\)\
\-\ smears\\:\\ 0\\.04059976274415285\ \(0\)\
\-\ lesion\\:\\ 0\\.040244051468218606\ \(0\)\
\-\ deferred\\:\\ 0\\.03970871835208777\ \(0\)\
\-\ pas\\:\\ 0\\.03970871835208777\ \(0\)\
\-\ fungi\\:\\ 0\\.03970871835208777\ \(0\)\
\-\ atypia\\:\\ 0\\.03893686059125238\ \(0\)\
\-\ alter\\:\\ 0\\.037647013473829205\ \(0\)\
\-\ pap\\:\\ 0\\.037096087579006516\ \(0\)\
\-\ turner\\:\\ 0\\.036593131642650274\ \(0\)\
\-\ hypercholesterolemia\\:\\ 0\\.036130457031820586\ \(0\)\
\-\ application\\:\\ 0\\.0357020872505852\ \(0\)\
\-\ did\\:\\ 0\\.03566957966465808\ \(0\)\
\-\ epidermal\\:\\ 0\\.03393687540346854\ \(0\)\
\-\ insidious\\:\\ 0\\.03393687540346854\ \(0\)\
\-\ offered\\:\\ 0\\.03364038237232663\ \(0\)\
\-\ stains\\:\\ 0\\.03364038237232663\ \(0\)\
\-\ 27th\\:\\ 0\\.03335835830198309\ \(0\)\
\-\ neutrophils\\:\\ 0\\.03308945647750394\ \(0\)\
\-\ respond\\:\\ 0\\.032832509873048255\ \(0\)\
\-\ dermis\\:\\ 0\\.031695456149082625\ \(0\)\
\-\ twice\\:\\ 0\\.03149261615017355\ \(0\)\
\-\ ulceration\\:\\ 0\\.030405609031659446\ \(0\)\
\-\ plaque\\:\\ 0\\.029780096981715905\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.02895292447512242\ \(0\)\
\-\ histopathology\\:\\ 0\\.02758651535336386\ \(0\)\
\-\ seminar\\:\\ 0\\.027485985048670978\ \(0\)\
\-\ history\\:\\ 0\\.027288197403631986\ \(0\)\
\-\ uniformed\\:\\ 0\\.027194477224238074\ \(0\)\
\-\ htn\\:\\ 0\\.027194477224238074\ \(0\)\
\-\ services\\:\\ 0\\.026652172280783423\ \(0\)\
\-\ dermatology\\:\\ 0\\.026652172280783423\ \(0\)\
\-\ contains\\:\\ 0\\.026398977930156872\ \(0\)\
\-\ \\:\\:\\ 0\\.026133521757009594\ \(0\)\
\-\ steroid\\:\\ 0\\.026077764917701318\ \(0\)\
\-\ daily\\:\\ 0\\.02555531369534138\ \(0\)\
\-\ papillary\\:\\ 0\\.025076194274498795\ \(0\)\
\-\ 2003\\:\\ 0\\.024819247670043107\ \(0\)\
\-\ annual\\:\\ 0\\.024756756825510068\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.0243372730518983\ \(0\)\
\-\ local\\:\\ 0\\.02268883985979621\ \(0\)\
\-\ 16\\:\\ 0\\.022351205396464333\ \(0\)\
\-\ circumscribed\\:\\ 0\\.02195513634191661\ \(0\)\
\-\ bleeding\\:\\ 0\\.02144261820847351\ \(0\)\
\-\ not\\:\\ 0\\.021413040550438182\ \(0\)\
\-\ had\\:\\ 0\\.02131618288139547\ \(0\)\
\-\ inflammation\\:\\ 0\\.02100424782470759\ \(0\)\
\-\ excision\\:\\ 0\\.020273125587082618\ \(0\)\
\-\ cells\\:\\ 0\\.019806050255202295\ \(0\)\
\-\ marked\\:\\ 0\\.0192767601192168\ \(0\)\
\-\ biopsy\\:\\ 0\\.017524238390963932\ \(0\)\
\-\ was\\:\\ 0\\.017137760500815377\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.016697065884370445\ \(0\)\
\-\ three\\:\\ 0\\.01665100710027116\ \(0\)\
\-\ \\,\\:\\ 0\\.015647980665739154\ \(0\)\
\-\ onset\\:\\ 0\\.015592030207659827\ \(0\)\
\-\ examination\\:\\ 0\\.015355046447829855\ \(0\)\
\-\ negative\\:\\ 0\\.014752139661126441\ \(0\)\
\-\ syndrome\\:\\ 0\\.014126627611182899\ \(0\)\
\-\ abnormal\\:\\ 0\\.014087238383323186\ \(0\)\
\-\ chronic\\:\\ 0\\.013913234872294797\ \(0\)\
\-\ she\\:\\ 0\\.013865815846555909\ \(0\)\
\-\ shows\\:\\ 0\\.013580194796120685\ \(0\)\
\-\ high\\:\\ 0\\.013517607289461362\ \(0\)\
\-\ trauma\\:\\ 0\\.01350872128183774\ \(0\)\
\-\ months\\:\\ 0\\.013490990142717152\ \(0\)\
\-\ one\\:\\ 0\\.013385730539367884\ \(0\)\
\-\ significant\\:\\ 0\\.013282353474301869\ \(0\)\
\-\ acute\\:\\ 0\\.01219583427229188\ \(0\)\
\-\ bilateral\\:\\ 0\\.011987385718580601\ \(0\)\
\-\ associated\\:\\ 0\\.011655852959004056\ \(0\)\
\-\ without\\:\\ 0\\.01163013390958474\ \(0\)\
\-\ or\\:\\ 0\\.01157829767588101\ \(0\)\
\-\ were\\:\\ 0\\.011215527957745209\ \(0\)\
\-\ well\\:\\ 0\\.011173878340859254\ \(0\)\
\-\ \\'s\\:\\ 0\\.010890442880734364\ \(0\)\
\-\ case\\:\\ 0\\.010806384005013126\ \(0\)\
\-\ but\\:\\ 0\\.01053470116204357\ \(0\)\
\-\ female\\:\\ 0\\.010154683649987476\ \(0\)\
\-\ presents\\:\\ 0\\.01009042945380304\ \(0\)\
\-\ treatment\\:\\ 0\\.009997785893646745\ \(0\)\
\-\ within\\:\\ 0\\.00942272490396579\ \(0\)\
\-\ disease\\:\\ 0\\.008073627405871121\ \(0\)\
\-\ there\\:\\ 0\\.007350956973786061\ \(0\)\
\-\ a\\:\\ 0\\.006877453210727189\ \(0\)\
\-\ an\\:\\ 0\\.00683043274153023\ \(0\)\
\-\ the\\:\\ 0\\.005593901693210292\ \(0\)\
\-\ year\\:\\ 0\\.005526620053600663\ \(0\)\
\-\ and\\:\\ 0\\.0052025724200063135\ \(0\)\
\-\ no\\:\\ 0\\.004973665611004635\ \(0\)\
\-\ for\\:\\ 0\\.0042144979690330354\ \(0\)\
\-\ on\\:\\ 0\\.004184341111938891\ \(0\)\
\-\ \\(\\:\\ 0\\.004175501307767979\ \(0\)\
\-\ \\)\\:\\ 0\\.004124495330134711\ \(0\)\
\-\ of\\:\\ 0\\.004040594247329078\ \(0\)\
\-\ with\\:\\ 0\\.0033816235864129983\ \(0\)\
\-\ to\\:\\ 0\\.002468601782907435\ \(0\)\
\-\ \\.\\:\\ 0\\.0024623955674459843\ \(0\)\
